Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
Jan 30, 2017 13:01 pm UTC| Business
PLYMOUTH MEETING, Pa., Jan. 30, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will participate in the following upcoming investment conferences: BIO CEO Investor...
BioSig Technologies Announces EU Institutional Investor Roadshow
Jan 30, 2017 13:01 pm UTC| Business
Minneapolis, MN, Jan. 30, 2017 -- BioSig Technologies, Inc.(OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion...
BioSig Technologies Announces EU Institutional Investor Roadshow
Jan 30, 2017 13:01 pm UTC| Business
Minneapolis, MN, Jan. 30, 2017 -- BioSig Technologies, Inc.(OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion...
Jan 30, 2017 13:01 pm UTC| Business
Sydney, Australia, Jan. 30, 2017 -- Heron Resources Ltd. (TSX: HER) (ASX: HRR) (Heron or the Company) announces its quarterly activities for the three months ended December 31, 2016. Details of the Company's results are...
Smart Sand, Inc. Announces New Capital Projects & Ongoing Contract Discussions
Jan 30, 2017 13:00 pm UTC| Business
THE WOODLANDS, Texas, Jan. 30, 2017 -- Smart Sand, Inc. (NASDAQ:SND) announced today that based on our assessment of increased demand for our products, particularly fine mesh sand, we have decided to increase the wet...
Independence Holding Company Repurchases Shares
Jan 30, 2017 13:00 pm UTC| Business
STAMFORD, Conn., Jan. 30, 2017 -- Independence Holding Company (NYSE:IHC) today announced that it repurchased 290,000 shares of its common stock for $5.8 million in a private transaction. IHC has also been repurchasing...
Zogenix Announces Issuance of U.S. Patent for ZX008 in Dravet Syndrome
Jan 30, 2017 13:00 pm UTC| Business
EMERYVILLE, Calif., Jan. 30, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, announced today the recent issuance...